Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Begg
    Begg
  2. Gonen
    Gonen
  3. Houston
    Houston
  4. Gallina
    Gallina
  5. Heller
    Heller
  6. Panageas
    Panageas
  7. Scher
    Scher
  8. Vickers
    Vickers

Groups

  1. Epidemiology and Biostatistics (8)
  2. Biostatistics Service (7)
  3. Population Sciences Research Program (6)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  5. Health Outcomes Research Group (5)
  6. Epidemiology Service (4)
  7. Molecular Pharmacology and Chemistry Program Faculty (4)
  8. Sloan Kettering Institute Faculty (4)
  9. Center for Pancreatic Cancer Research (2)
  10. Department of Medicine (2)
Search Within
  1. "Controlled Clinical Trials"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (5)
Groups
  1. Epidemiology and Biostatistics (8)
  2. Biostatistics Service (7)
  3. Population Sciences Research Program (6)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  5. Health Outcomes Research Group (5)
  6. Epidemiology Service (4)

More Groups

People
  1. Colin Begg (4)
  2. Collette Houston (2)
  3. Elinor Miller (2)
  4. Madhu Mazumdar (2)
  5. Mithat Gonen (2)
  6. Alexander Smith (1)

More People

Years
  1. 2003 (4)
  2. 2002 (1)
  3. 2001 (1)
  4. 2000 (2)
  5. 1992 (2)
  6. 1990 (1)

More Years

Publications
  1. Controlled Clinical Trials (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficiency of strta matched case-control studies with multiple controls per case in survival data setting
    Meeting Abstract

    Mazumdar, M.; Tu, D.
    Controlled Clinical Trials (2003)

    Fulltext@MSK | Save
  • Comparison of methods for estimating area under the toxicity curve in the QTWiST setting
    Meeting Abstract

    Bacik, J.; Mazumdar, M.; Zbrozek, A.
    Controlled Clinical Trials (2003)

    Fulltext@MSK | Save
  • Use of a single global assessment to reduce missing data in a clinical trial with follow-up at one year
    Journal Article

    Vickers, A. J.; McCarney, R.
    Controlled Clinical Trials (2003)

    Fulltext@MSK | Save
  • Planning for subgroup analysis: A case study of treatment-marker interaction in metastatic colorectal cancer
    Journal Article

    Gonen, M.
    Controlled Clinical Trials (2003)

    Fulltext@MSK | Save
  • An optimal two-stage phase II design utilizing complete and partial response information separately
    Journal Article

    Panageas, K. S.; Smith, A.; Gonen, M.; Chapman, P. B.
    Controlled Clinical Trials (2002)

    Fulltext@MSK | Save
  • Isotonic designs for phase I trials
    Journal Article

    Leung, D. H. Y.; Wang, Y. G.
    Controlled Clinical Trials (2001)

    Fulltext@MSK | Save
  • Ruminations on the intent-to-treat principle
    Journal Article

    Begg, C. B.
    Controlled Clinical Trials (2000)

    Fulltext@MSK | Save
  • The phase II/III transition: Toward the proof of efficacy in cancer clinical trials
    Journal Article

    Fazzari, M.; Heller, G.; Scher, H. I.
    Controlled Clinical Trials (2000)

    Fulltext@MSK | Save
  • The development of data collection tools to assist in protocol management
    Meeting Abstract

    Houston, C.; Frankel, J.; Quinlivan, S.; Gallina, E.; Berkery, R.; Begg, C.
    Controlled Clinical Trials (1992)

    Fulltext@MSK | Save
  • Selecting a RDBMS for a multi-disciplinary clinical research database
    Meeting Abstract

    Wu, D.; Begg, C.; Houston, C.; Miller, E.
    Controlled Clinical Trials (1992)

    Fulltext@MSK | Save